FibrosarcomaSymptoms, Doctors, Treatments, Advances & More
Learn About Fibrosarcoma
- Fibrosarcoma
Cleveland Clinic Main Campus
Gary Schwartz is a Hematologist Oncology provider in Cleveland, Ohio. Dr. Schwartz has been practicing medicine for over 47 years and is rated as an Elite provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.
UT MD Anderson Cancer Center
Christina Roland is a Surgical Oncologist in Cary, North Carolina. Dr. Roland is rated as an Elite provider by MediFind in the treatment of Fibrosarcoma. Her top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Rockefeller Outpatient Pavilion
Sandra D'angelo is an Oncologist in New York, New York. Dr. D'angelo is rated as an Elite provider by MediFind in the treatment of Fibrosarcoma. Her top areas of expertise are Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.
Summary: The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardless of the tumor's tissue type or location. Patients who have not responded to standard treatments will be included, and ...
Summary: 3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genetically engineered to express B7-H3-CARs for patients ≤ 21 years old, with relapsed/refractory B7-H3+ solid tumors. This study will evaluate the safety and maximum tolerated dose of B7-H3-CAR T cells.The purpose of this study is to find the ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center